AGNT(AGNT)
AGNT
$4.08—
NASDAQ
$4.08—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $5.06B | $5.36B |
| Low | $5.04B | $5.34B |
| High | $5.08B | $5.38B |
| EBITDA Avg | $36M | $22M |
| Low | $35M | $22M |
| High | $36M | $22M |
| EBIT Avg | $26M | $11M |
| Low | $25M | $11M |
| High | $26M | $11M |
| Net Income Avg | $20M | $9M |
| Low | $20M | $9M |
| High | $20M | $9M |
| EPS Avg | $0.13 | $0.06 |
| Low | $0.13 | $0.06 |
| High | $0.13 | $0.06 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $1.38B | $1.23B | $1.09B | $1.55B | $1.42B | $1.28B |
| Low | $1.37B | $1.22B | $1.08B | $1.54B | $1.41B | $1.27B |
| High | $1.39B | $1.24B | $1.10B | $1.57B | $1.44B | $1.30B |
| EBITDA Avg | $12M | $8M | $-6M | $17M | $797,461 | $-11M |
| Low | $12M | $8M | $-6M | $17M | $774,815 | $-11M |
| High | $12M | $8M | $-6M | $17M | $815,252 | $-11M |
| EBIT Avg | $9M | $6M | $-8M | $15M | $-2M | $-13M |
| Low | $9M | $5M | $-8M | $14M | $-2M | $-13M |
| High | $9M | $6M | $-8M | $15M | $-2M | $-13M |
| Net Income Avg | $7M | $4M | $-8M | $12M | $-2M | $-13M |
| Low | $7M | $4M | $-8M | $12M | $-2M | $-13M |
| High | $8M | $4M | $-8M | $12M | $-2M | $-13M |
| EPS Avg | $0.04 | $0.03 | $-0.05 | $0.07 | $-0.01 | $-0.08 |
| Low | $0.04 | $0.03 | $-0.05 | $0.07 | $-0.01 | $-0.08 |
| High | $0.05 | $0.03 | $-0.05 | $0.07 | $-0.01 | $-0.08 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |